Author:
Genç Yasin,Taner Ender,Candansayar Selcuk
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference37 articles.
1. Essock SM, Hargreaves WA. Clozapine eligibility among state hospital patients.Schizophr Bull. 1996;22:15–25.
2. Barnes TRE, Buckley P, Schultz SC. Treatment resistant schizophrenia. In: Hirsch SR, Weinberger D, eds.Schizophrenia. Oxford, Mass: Blackwell Science; 2003:489–517.
3. Taner E, Cosar B, Isik E. The effects of the changes in symptoms of schizophrenia over functioning: two years of clozapine follow-up study [in Turkish].Psych Turkey. 2002;4:84–91.
4. McEvoy JP, Hogarty GE, Steingard S. Optimal dose of neuroleptic in acute schizophrenia: a controlled study of the neuroleptic threshold and higher haloperidol dose.Arch Gen Psychiatry. 1991;48:739–745.
5. Kane JM. The current status of neuroleptic therapy.J Clin Psychiatry. 1989;50:322–328.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献